Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Medicare and Medicaid
RedPath Integrated Pathology Awarded Medicare Reimbursement Coverage for PathFinderTG
July 15th, 2007
RedPath Integrated Pathology, Inc. ("RedPath") announced that its genomic-based cancer diagnostic test, PathFinderTG(R), has been approved by Highmark Medicare Services for reimbursement coverage. "The PathFinderTG test helps to resolve even the most difficult cancer diagnoses, allowing for clarity in indeterminate, equivocal, suspicious and non-diagnostic specimens in a wide variety of cancer types," said Mary Del Brady, president and CEO of RedPath. "The reimbursement approval means that this powerful diagnostic tool can now be readily available to Medicare beneficiaries." Currently, PathFinderTG is offered in more than half of the major cancer...
Source: Aging & Elder Health Week (2007-07-15)
|
